Medtronic: EPS up 7% in Q3

(CercleFinance.com) - Medtronic reported non-GAAP net income of $1.
79 billion for its third fiscal quarter, representing EPS up 7% to $1.39, on revenues of $8.29 billion, up 2.5% (+4.1% organic).

"We are starting to see the fruits of our long-term investments in breakthrough innovations, such as electroporation, to drive growth in some of medtech's most attractive markets", explains CEO Geoff Martha.

For its full fiscal year 2024-25, the medical equipment supplier confirms it is targeting non-GAAP EPS of between $5.44 and $5.50, as well as annual organic revenue growth of between 4.75 and 5%.

Copyright (c) 2025 CercleFinance.com. All rights reserved.